Growth through partnerships Stratus has recently formed multiple strategic partnerships with EEG and neurodiagnostic device players, suggesting a proven path to scale remote EEG services with third-party collaboration. This creates opportunities to position complementary product bundles, integration, and joint go-to-market efforts with partners like Epitel and BioSerenity.

Expansion readiness With a focus on nationwide expansion of remote EEG monitoring and recent leadership appointment, there is an openness to scale operations, services, and coverage. This signals a potential need for scalable technology integrations, professional services, and training partnerships to support larger hospital networks.

Tech modernizer A modern technology stack including Databricks, Snowflake, and Salesforce Marketing Cloud indicates a data-driven, cloud-enabled operation. This presents opportunities to sell data analytics services, security/compliance enhancements, or AI-driven workflow improvements for clinical and back-office teams.

Healthcare focus As a neurodiagnostic and EEG solutions provider, Stratus operates in a highly regulated healthcare space with demand for efficient, compliant, and scalable solutions. Potential sales angles include EHR/SIEM integrations, remote monitoring platforms, and managed services that improve EEG throughput and patient outcomes.

Growth capital signals Revenue in the $10–$25 million range combined with multiple deals and leadership growth suggests a company poised for accelerated investment in technology, data, and services. This presents opportunities for larger, multi-year contracts, expanded deployment, and enterprise-grade solutions.